StemGenn Therapeutics is the leading cell therapy and regenerative medicine services company in India which leads the way in the development and commercialization of cellular therapies and stem cell research in India. The company is in the forefront of stem cell therapy for autoimmune diseases like COPD, spinal cord injuries, stroke, motor neuronal disease (ALS), multiple sclerosis, anti- aging treatments, rheumatoid arthritis, diabetes and Chron’s disease. The services offered by the company also extends to areas like due diligence evaluations, processing and storage, tissue collection, process and product development, distribution and transportation, product manufacturing.
When one undergoes stem cell treatment, one can be completely assured that it’s completely non-invasive, administered intravenously and occasionally, intra-articular or intrathecal, in neurological and orthopedic cases. When it comes to eye related diseases, the treatment administered is retrobulbar or itraviterous.
Haematopoetic stem cell transplant is a well-established clinical practice since decades for blood disorders. Autologous adult stem cell transplant has tremendous potential to regenerate damaged tissues and cells with high safety and efficacy worldwide.
The best part about this autologous stem cell transplant is its affordability and cost effectiveness, two factors which make it far more preferable as compared to long repetitive treatments or surgery.
This form of treatment uses the blood or the tissues of the patient, thereby significantly diminishing the occurrence of infection and rejection. The benefits of stem cell therapy, as well as the easy, safe and painless procedure associated with it, have been acknowledge throughout the world. The entire treatment usually lasts to one or two days.
StemGenn Therapeutics leads the way in cell therapy and regenerative medicine services and is at the forefront of commercialization and development of cellular therapies and stem cell research. The services provided by Stemgenn extend to areas like cGMP-compliant cell manufacturing and consulting that address financial, technical, regulatory, process and training and quality system strategies. Stemgenn provides a whole host of support and consulting which are associated with due diligence evaluations, tissue collection, process and product development, validation, product manufacturing, distribution and transportation.
StemGenn Therapeutics has established as a leader in cutting-edge stem cell therapy and regenerative medicine revolution in India. Although the use of various kinds of stem cells is established in orthopedic and neurological diseases like spinal cord injuries, stroke, multiple sclerosis, motor neuronal disease (ALS), rheumatoid arthritis, Chron’s disease, autoimmune diseases like COPD and diabetes, besides others, their focus now is on the area of anti-aging.
The company’s goal is to initiate a transformation in the science of skincare and enable it to become more natural, thereby bringing about a close partnership between science and nature. The goal is to provide the most efficient products that heal the skin and lend it a youthful radiance.
The domain of anti-aging is presently connected with mesenchymal stem cells and hematopoietic stem which help to rebuild cartilage and regenerate tissue, tendons, muscles, nerve cells and ligaments.
StemGenn Therapeutics prides itself on providing safe, effective and non-surgical alternatives in place of total joint replacements, osteoarthritis and orthopedic disorders. This enables a person to enhance the quality of his/her life, get relief from pain and injuries and lead an active lifestyle once again without resorting to dangerous, invasive and expensive surgeries.
StemGenn Therapeutics strives to fulfill the unfulfilled requirements of regenerative medicine, stem cell labs, developing new products, training programs and much more.